Trials / Unknown
UnknownNCT04512222
EARLY-MYO-AF Registry
EARLY-MYO-AF (EARLY Integrated Therapies on MYOcardial Function Improvements in Patients With Atrial Fibrillation) Registry
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- RenJi Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this registry is to depict the myocardial function improvement in AF patients by integrated therapy and to assess the prognostic discrepancies of various intervention modalities. Information will be collected prospectively in about 5000 AF patients. Subjects will be followed for up to 3 years.
Detailed description
This is a prospective, single-centered, non-randomized, observational registry study of AF patients that undergo radio-frequency catheter ablation, left atrial appendage occlusion or surgical ablation. Information of other medication intervention and clinical outcomes are also prospectively collected in the database. This project will establish a prospective registry of 5000 AF patients with follow-ups of up to 3 years. The aim of the project will be as following: 1. To investigate pathophysiological changes of both atrial and ventricular myocardial function in AF patients. 2. To identify clinical indices (including baseline, comorbidities, medication or operational interventions) that are associated with adverse clinical outcomes. 3. To spot potential therapeutical targets in the continuum of AF: from risk-factors elimination to mortality and disability prevalence reduciton.
Conditions
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2022-12-31
- Completion
- 2025-12-31
- First posted
- 2020-08-13
- Last updated
- 2020-08-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04512222. Inclusion in this directory is not an endorsement.